Logo
x

Search

Subscribe Now

Glioblastoma

Mustang Bio to Initiate P-I Clinical Trial for MB-101 + MB-108 for the Treatment of Glioblastoma

Mustang Bio to Initiate P-I Clinical Trial for MB-101 + MB-108 for the Treatment of Glioblastoma

  • April 13, 2022
Gan & Lee Receives the US FDA's Fast Track Designation for GLR2007 for the Treatment of Patients with Glioblastoma

Gan & Lee Receives the US FDA's Fast Track Designation for GLR2007 for the Treatment of Patients with Glioblastoma

  • February 1, 2021
PharmaShots Interview: Novocure's William F. Doyle Shares Insight on Company's Accomplishments in the Treatment of Glioblastoma and Mesothelioma

PharmaShots Interview: Novocure's William F. Doyle Shares Insight on Company's Accomplishments in the Treatment of Glioblastoma an...

  • December 9, 2020
Novocure and ZaiLab's Optune Receive NMPA's Approval for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

Novocure and ZaiLab's Optune Receive NMPA's Approval for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

  • May 14, 2020
AbbVie Reports Results of Depatux-M (depatuxizumab mafodotin) in P-III INTELLANCE-1 Study for Glioblastoma

AbbVie Reports Results of Depatux-M (depatuxizumab mafodotin) in P-III INTELLANCE-1 Study for Glioblastoma

  • May 20, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.